GLS2 and neoplasm: To determine whether MSLN scFv-LGA-PEI NPs with NAs could target MSLN-expressing cancer tumor tissues in vivo, we orthotopically implanted the PDX line (PAN3) into the pancreas of an NSG mouse (NOD scid gamma mouse) for 3 weeks, when the tumor was established.